Author: healthadmin

The largest published prospective evaluation of an off-label targeted cancer therapy shows that more patients may benefit from existing drugs. After enrolling more than 1,600 patients in the Dutch multicenter DRUP trial, the team presented their results: nature today. “Our findings highlight the fact that effective off-label use is possible, but should only be done within the setting of a clinical trial.” The pan-cancer DRUP trial aims to enable more individualized treatment options by expanding the use of existing drugs beyond their approved indications. Over the past 10 years, this trial has provided off-label treatment opportunities to more than 1,600…

A long-standing mystery in cancer treatment is how tumor cells become resistant to drugs, even drugs they have never encountered before. Researchers at New York University Langone Health have proposed a model that can explain how cancer cells adapt to environmental stress, an approach that could lead to new treatments. Published online April 15 as a cover story for the journal naturethis Perspective focuses on a family of proteins called AP-1 that are rapidly activated within cells in response to stressful situations, such as exposure to chemotherapy. Although the AP-1 protein has been studied for decades, the authors propose that…

Dr. David Schwimmer, North America’s leading expert on giant crocodiles Deinosuchus He is a professor of geology at Columbus State University and helped bring a prehistoric giant back to life. His decades of research played a key role in building the first fully attached, scientifically accurate skeletal replica. Deinosuchus schweimeri. Long described as the “dinosaur killer,” this giant predator was probably at the top of the food chain at the time. They lived in the eastern United States between 83 and 76 million years ago. Deinosuchus schweimeri It was a relative of the modern crocodile, which preyed on dinosaurs and…

After three years of war, Sudan is now in the world’s largest humanitarian crisis, with 34 million people in need of aid and 21 million without access to health services, with repeated attacks crippled a health system already weakened by disease and starvation. While the situation is improving in some states, the health crisis is deepening in areas where fighting continues. Disease incidence and malnutrition are on the rise, while access to health services is shrinking and underfunded. Sudan’s war is destroying lives and denying people their most basic rights, including health, water, food and security. Health systems are…

Despite new supply commitments from Gilead Sciences, Médecins Sans Frontières/Médecins Sans Frontières (MSF) is poking holes in the company’s plans to support global access to the twice-yearly HIV pre-exposure prophylaxis (PrEP) drug Eztugo. Gilead announced on Tuesday that it would expand its Eztugo Supply program to reach an additional 1 million people in countries with high incidence and limited resources, reaching a total of 3 million people by 2028. The access plan is in collaboration with the U.S. Department of State, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund, all of which are “experts in…

A study from Scarborough College at the University of Toronto found that feeling mentally sharp can significantly improve how much you accomplish in a day. Researchers have found that when people think clearly and efficiently, the effect can be equivalent to approximately 40 minutes of additional productive work. Published in scientific progressa study followed participants over a 12-week period to better understand why people sometimes have trouble following through with their plans. The findings point to day-to-day changes in mental acuity as an important factor. On days when participants felt more mentally alert, they were more likely to set and…

Recent research published in journals neuropharmacology provide evidence that a single dose of the psychedelic compound N,N-dimethyltryptamine can produce rapid and long-lasting antidepressant effects in mice. This study suggests that this naturally occurring psychedelic drug may reduce anxiety and may offer potential benefits compared to existing fast-acting treatments such as S-ketamine. These findings highlight the potential of psychedelic compounds as future treatments for severe and treatment-resistant mental health conditions. Major depressive disorder is a widespread mental illness that affects millions of people worldwide. Standard treatments usually take several weeks to become effective, leaving patients vulnerable during the waiting period. Approximately…

“Do you want to stick your finger in a dinosaur’s brain?” asked Simba Srivastava. In a paleontology lab lined with cabinets of ancient fossils, a Virginia Tech undergraduate holds up a rough, hole-filled skull. “This is a uniquely disgusting specimen,” Srivastava said. “It’s so gross. I feel like I’m going to throw up when I see a human skull like this.” Despite its poor condition, the senior earth science major spent two years carefully reconstructing the fossil and figuring out where it fits into the evolutionary history of dinosaurs. His works are paleontology papersprovides new insights into how dinosaurs established…

AI giant Anthropic has appointed Novartis CEO Vasu Narasimhan to its board of directors, as ties between the pharmaceutical industry and Silicon Valley deepen. Narasimhan shares Anthropic’s vision that healthcare and life sciences are among the areas where AI has the greatest potential to improve the quality of human life, Anthropic said in an April 14 announcement. “Bringing powerful new technologies to people safely and at scale is something we think about every day at Anthropic,” Anthropic co-founder and president Daniela Amodei said in a statement Tuesday. “Vasu has been doing just that for years, and we are grateful that…

For Astellas Pharma Chief Manufacturing Officer Dr. Rao Mantri, who has been in the role for just over a year, production is about more than just ensuring a reliable supply of medicines. Manufacturing also serves as a critical bridge connecting promising research to patients in the real world. “Astellas Pharma’s manufacturing business is not only focused on serving patients, but we also have tremendous strength in multiple modalities,” Mantri said during a recent meeting with Fiers at the American Biomanufacturing Summit in San Francisco. “So the challenge when I started was how do you actually create a manufacturing organization as…